Submission for OMB Review; 30-Day Comment Request Population Assessment of Tobacco and Health (PATH) Study (NIDA), 61829-61830 [2015-26100]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 198 / Wednesday, October 14, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Scientific and
Technical Review Board on Biomedical and
Behavioral Research Facilities.
Date: October 28, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: Ross D Shonat, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6196,
MSC 7804, Bethesda, MD 20892, 301–435–
2786, ross.shonat@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
tkelley on DSK3SPTVN1PROD with NOTICES
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 7, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–25995 Filed 10–13–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:39 Oct 13, 2015
Jkt 238001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Support for
Conference and Scientific Meetings (R13).
Date: October 26, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Minority
Health and Health Disparities, Internet
Assisted Meeting, 6707 Democracy Blvd.,
Suite 800, Bethesda, MD 20892
Contact Person: Xinli Nan, M.D., Ph.D.,
Scientific Review Officer, National Institute
on Minority Health and Health Disparities,
National Institutes of Health, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 435–3481, Xinli.Nan@nih.gov.
Dated: October 8, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–26103 Filed 10–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Population
Assessment of Tobacco and Health
(PATH) Study (NIDA)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
61829
the Federal Register on June 30, 2015,
pages 37276–37277 and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_Submission@
omb.eop.gov or by fax to (202) 395–
6974, Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project,
contact: Dr. Kevin P. Conway, Deputy
Director, Division of Epidemiology,
Services, and Prevention Research,
NIDA, NIH, 6001 Executive Boulevard,
Room 5185, Rockville, MD 20852; or
call non-toll-free number (301) 443–
8755 or Email your request, including
your address to: PATHprojectofficer@
mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Cognitive
Interviews and Focus Groups for the
Population Assessment of Tobacco and
Health (PATH) Study (NIDA), 0925–
0663, Expiration Date 11/30/2015,
Revision, National Institute on Drug
Abuse, National Institutes of Health
(NIH), in partnership with the Food and
Drug Administration (FDA).
Need and Use of Information
Collection: This is a revision request for
the Population Assessment of Tobacco
and Health (PATH) Study to conduct
cognitive interviews and focus groups,
to support the development of the
Study’s questionnaires and other
materials. The PATH Study is a national
longitudinal cohort study of tobacco use
behavior and health among the U.S.
household population of adults age 18
and older and youth ages 12 to 17; the
Study conducts annual interviews and
collects biospecimens from adults to
inform FDA’s regulatory actions under
the Family Smoking Prevention and
E:\FR\FM\14OCN1.SGM
14OCN1
61830
Federal Register / Vol. 80, No. 198 / Wednesday, October 14, 2015 / Notices
Control Act. Cognitive interviews and
focus groups are qualitative methods to
assess how people interpret, process,
retrieve, and respond to phrases,
questions, response options, and
product images that may be used in the
development of the PATH Study’s
questionnaires and other materials.
These methods have previously been
used to help the PATH Study improve
the comprehensibility of its materials
for Study participants, and to increase
efficiencies in data collection and
reduce duplication and its associated
burden on participants and the public.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
annualized burden hours are 2,617.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
Activity name
Completing eligibility screener .............................................
Examining concepts to be measured in PATH Study .........
Examining assent forms for participation in PATH Study ...
Examining consent forms for participation in PATH Study
Examining other forms and materials to support PATH
Study data collection ........................................................
Examining PATH Study questionnaires ...............................
Dated: October 7, 2015.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015–26100 Filed 10–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel Innovative
Technologies for Cancer Research.
Date: November 5–6, 2015.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
7W246 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nicholas J. Kenney, Ph.D.
Scientific Review Officer Research
VerDate Sep<11>2014
18:25 Oct 13, 2015
Jkt 238001
Number of
respondents
Frm 00041
Average
burden per
response
(in hours)
Total annual
burden hours
Youth
Adults
Youth
Adults
Youth
Adults
1,600
2,400
100
200
200
200
1
1
1
1
1
1
10/60
10/60
90/60
90/60
90/60
90/60
267
400
150
300
300
300
Adults
Youth
Adults
200
100
300
1
1
1
90/60
90/60
90/60
300
150
450
Technology and Contract Review Branch
Division of Extramural Activities National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W246 Rockville, MD 20850
240–276–6374 nicholas.kenney@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel
Quantitative Imaging for Evaluation of
Responses to Cancer Therapies.
Date: November 12, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
7W246 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nicholas J. Kenney, Ph.D.
Scientific Review Officer Research
Technology and Contract Review Branch
Division of Extramural Activities National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W246 Rockville, MD 20850
240–276–6374 nicholas.kenney@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel Advanced
Development and Validation of Emerging
Molecular Analysis Technologies for Cancer
Research.
Date: November 18, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
2E914 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Gerard Lacourciere, Ph.D.
Scientific Review Officer Research
Technology and Contract Review Branch
Division of Extramural Activities National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W248 Rockville, MD 20850
240–276–5457 gerard.lacourciere@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI Lasker
Clinical Research Scholars Program.
Date: November 19, 2015.
PO 00000
Number of
responses per
respondent
Fmt 4703
Sfmt 4703
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
7W126 Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caron Lyman, Ph.D. Chief,
Scientific Review Officer Research Programs
Review Branch Division of Extramural
Activities National Cancer Institute 9609
Medical Center Drive, Room 7W126
Bethesda, MD 20892–9750 240–276–6348
lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group Subcommittee
A—Cancer Centers.
Date: December 4, 2015.
Time: 8:00 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications..
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road
Rockville, MD 20852.
Contact Person: Shamala K. Srinivas, Ph.D.
Associate Director Office of Referral, Review,
and Program Coordination Division Of
Extramural Activities National Cancer
Institute, NIH 9609 Medical Center Drive,
Room 7W530 Bethesda, MD 20892–8328
240–276–6442 ss537t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel Cancer
Center Support Grant.
Date: December 4, 2015.
Time: 10:45 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road
Bethesda, MD 20852.
Contact Person: David G. Ransom, Ph.D.
Scientific Review Officer Resources and
Training Review Branch Division of
Extramural Activities National Cancer
Institute, NIH 9609 Medical Center Drive,
Room 7W124 Rockville, MD 20850 240–276–
6351 david.ransom@nih.gov.
E:\FR\FM\14OCN1.SGM
14OCN1
]]>Agencies
[Federal Register Volume 80, Number 198 (Wednesday, October 14, 2015)]
[Notices]
[Pages 61829-61830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request Population
Assessment of Tobacco and Health (PATH) Study (NIDA)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH) has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on June 30, 2015, pages 37276-37277 and allowed 60 days for
public comment. No public comments were received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Institutes of Health may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_Submission@omb.eop.gov or by fax to (202) 395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments or request more information on the
proposed project, contact: Dr. Kevin P. Conway, Deputy Director,
Division of Epidemiology, Services, and Prevention Research, NIDA, NIH,
6001 Executive Boulevard, Room 5185, Rockville, MD 20852; or call non-
toll-free number (301) 443-8755 or Email your request, including your
address to: PATHprojectofficer@mail.nih.gov. Formal requests for
additional plans and instruments must be requested in writing.
Proposed Collection: Cognitive Interviews and Focus Groups for the
Population Assessment of Tobacco and Health (PATH) Study (NIDA), 0925-
0663, Expiration Date 11/30/2015, Revision, National Institute on Drug
Abuse, National Institutes of Health (NIH), in partnership with the
Food and Drug Administration (FDA).
Need and Use of Information Collection: This is a revision request
for the Population Assessment of Tobacco and Health (PATH) Study to
conduct cognitive interviews and focus groups, to support the
development of the Study's questionnaires and other materials. The PATH
Study is a national longitudinal cohort study of tobacco use behavior
and health among the U.S. household population of adults age 18 and
older and youth ages 12 to 17; the Study conducts annual interviews and
collects biospecimens from adults to inform FDA's regulatory actions
under the Family Smoking Prevention and
[[Page 61830]]
Control Act. Cognitive interviews and focus groups are qualitative
methods to assess how people interpret, process, retrieve, and respond
to phrases, questions, response options, and product images that may be
used in the development of the PATH Study's questionnaires and other
materials. These methods have previously been used to help the PATH
Study improve the comprehensibility of its materials for Study
participants, and to increase efficiencies in data collection and
reduce duplication and its associated burden on participants and the
public.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total annualized burden hours
are 2,617.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number of burden per Total annual
Activity name respondent respondents responses per response (in burden hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Completing eligibility screener. Youth 1,600 1 10/60 267
Adults 2,400 1 10/60 400
Examining concepts to be Youth 100 1 90/60 150
measured in PATH Study.........
Adults 200 1 90/60 300
Examining assent forms for Youth 200 1 90/60 300
participation in PATH Study....
Examining consent forms for Adults 200 1 90/60 300
participation in PATH Study....
Examining other forms and Adults 200 1 90/60 300
materials to support PATH Study
data collection................
Examining PATH Study Youth 100 1 90/60 150
questionnaires.................
Adults 300 1 90/60 450
----------------------------------------------------------------------------------------------------------------
Dated: October 7, 2015.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015-26100 Filed 10-13-15; 8:45 am]
BILLING CODE 4140-01-P
